07:00 , Oct 17, 2016 |  BC Week In Review  |  Clinical News

Bavituximab: Interim Phase III data

Interim data from the double-blind, international Phase III SUNRISE trial in about 582 previously treated patients with stage IIIb/IV non-squamous NSCLC showed that once-weekly IV bavituximab plus docetaxel missed the primary endpoint of improving median...
07:00 , Sep 10, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Autoimmune disease Antiphospholipid syndrome (APS) ...
08:00 , Dec 3, 2007 |  BC Week In Review  |  Clinical News

AtherOx test kit diagnostic data

In a Japanese trial of the in vitro AtherOx kit, significantly higher serum levels of oxidized LDL/B2GPI complexes were seen in acute coronary syndrome (ACS) patients compared with volunteers. The study was sponsored by CONX...